CRON
Cronos Group Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Last price
3.29
▲ 0.07 (2.17%)
MARKET · —
Price
Open
3.30
Prev close
3.22
Day high
3.32
Day low
3.22
Volume
1.31M
Market cap
$1.22B
P/E (TTM)
17.42
52W range
2.28 – 3.43
Trailing performance
Returnvs SPY
1W
+5.41%
+6.8%
1M
+20.80%
+17.1%
3M
+21.25%
+18.1%
6M
+22.59%
+11.5%
YTD
+25.86%
+13.6%
1Y
+36.78%
+16.8%
3Y
+83.89%
+9.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.22B
Enterprise value$472.50M
Revenue (TTM)$179.09M
Gross profit$77.04M
EBITDA$11.88M
Net income$69.98M
EPS (TTM)$0.19
Free cash flow$6.11M
Total cash$797.02M
Total debt$1.29M
Book value / share$2.88
Shares outstanding368.41M
Float186.99M
Short % of float1.85%
Dividend yield—
Beta (5Y)1.24
Valuation & profitability ratios
Trailing P/E17.42
Forward P/E-82.75
PEG ratio—
Price / sales—
Price / book1.15
EV / revenue2.64
EV / EBITDA39.78
Gross margin43.02%
Operating margin15.44%
Profit margin39.08%
Return on equity7.05%
Return on assets-0.10%
Debt / equity0.12
Current ratio16.18
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $200.54M | $169.71M | $118.41M | $125.04M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$12.92M | $59.28M | -$100.38M | -$229.57M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$12.92M | $59.28M | -$100.38M | -$229.57M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.01 | 0.13 | +802.1% |
| Mar 2026 | 0.01 | 0.05 | +682.3% |
| Dec 2025 | 0.02 | 0.00 | -100.0% |
| Sep 2025 | 0.00 | 0.10 | 0.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.04 | 2 | $69.28M | +34.9% |
| Next quarter | 0.04 | 2 | $84.45M | +38.6% |
| Current year | 0.22 | 4 | $278.76M | +39.0% |
| Next year | 0.16 | 3 | $322.76M | +15.8% |
Analyst targets & ownership
Mean target$2.55
High target$2.55
Low target$2.55
Implied upside-22.53%
Analyst count1
ConsensusSTRONG BUY
Strong buy / Buy0 / 3
Hold1
Sell / Strong sell0 / 0
Held by insiders48.85%
Held by institutions15.48%
Institutions holding242
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
179.97M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 12, 26 | Buggy (Shannon) Senior Officer of Issuer |
— | 20.62K | — | Direct |
| May 12, 26 | Buggy (Shannon) Senior Officer of Issuer |
EXERCISE | 9.18K | $25.24K | Direct |
| May 12, 26 | Doucet (Terrence Gregory Joseph) Senior Officer of Issuer |
— | 10.60K | — | Direct |
| May 12, 26 | Doucet (Terrence Gregory Joseph) Senior Officer of Issuer |
EXERCISE | 5.20K | $14.24K | Direct |
| May 12, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
— | 9.41K | — | Direct |
| May 12, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
EXERCISE | 3.70K | $10.18K | Direct |
| May 12, 26 | Wagner (Adam Shmuel) Senior Officer of Issuer |
— | 10.37K | — | Direct |
| May 10, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
EXERCISE | 2.90K | $7.36K | Direct |
| May 10, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
— | 5.11K | — | Direct |
| May 10, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
EXERCISE | 1.88K | $4.77K | Direct |
| May 10, 26 | Wagner (Adam Shmuel) Senior Officer of Issuer |
— | 10.06K | — | Direct |
| May 10, 26 | Wagner (Adam Shmuel) Senior Officer of Issuer |
— | 10.41K | — | Direct |
| May 10, 26 | Weigensberg (Aaron Arye) Senior Officer of Issuer |
— | 3.12K | — | Direct |
| May 10, 26 | Kenost (Jared Matthew) Senior Officer of Issuer |
— | 7.54K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Buggy (Shannon) |
Senior Officer of Issuer | 187.50K | Grant of options |
Doucet (Terrence Gregory Joseph) |
Senior Officer of Issuer | 115.79K | Grant of options |
Gorenstein (Michael Ryan) |
Director of Issuer | 13.34M | Grant of options |
Jacobson (Jeffrey David) |
Senior Officer of Issuer | 507.23K | Grant of options |
Kenost (Jared Matthew) |
Senior Officer of Issuer | 46.67K | Grant of options |
Shlimak (Anna) |
Senior Officer of Issuer | 368.36K | Grant of options |
Wagner (Adam Shmuel) |
Senior Officer of Issuer | 103.99K | Grant of options |
Weigensberg (Aaron Arye) |
Senior Officer of Issuer | 211.56K | Grant of options |
Moving averages & technicals
SMA 10
3.17
+3.69% from price
SMA 20
3.03
+9.33% from price
SMA 50
2.86
+15.71% from price
SMA 100
2.77
+18.94% from price
SMA 200
2.69
+23.12% from price
EMA 12
3.15
+4.52% from price
EMA 26
3.02
+8.77% from price
EMA 50
2.92
+12.76% from price
RSI (14)
69.4
Neutral
MACD (12,26,9)
0.12
Hist 0.02
ATR (14)
0.13
3.83% of price
Realised vol 30D
42.6%
Annualised
Bollinger upper
3.38
20, 2σ
Bollinger lower
2.67
20, 2σ
50 / 200 cross
Golden
2.86 vs 2.69
Trend bias
Above 200
+23.12%
Risk profile
Beta vs SPY
0.78
Less volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
42.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-26.9%
Peak to trough
Max drawdown 5Y
-75.9%
Peak to trough
ATR 14
0.13
3.83% of price
Beta (reported)
1.24
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.24
Call-heavy session
Put / call open interest
0.43
Positioning, not flow
Max pain
3.00
-9.4% from spot
ATM implied vol
47.7%
Nearest strike to spot
Skew (10% OTM)
+16.0%
Puts bid over calls
Call volume
105
Contracts, this expiry
Put volume
25
Contracts, this expiry
Heaviest call OI
3.50
1.16K contracts
Heaviest put OI
3.00
251 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate Hike
Zacks · 2d ago
Surging Earnings Estimates Signal Upside for Cronos (CRON) Stock
Zacks · 4d ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · 12d ago
Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests – Quarterly Update Report
Exec Edge · 14d ago
Cronos Group Inc (CRON) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ...
GuruFocus.com · 16d ago
Why Cronos Group (TSX:CRON) Is Up 6.4% After Swinging To US$32 Million Quarterly Profit
Simply Wall St. · 16d ago
Cronos Group Q2 Earnings Call Highlights
MarketBeat · 16d ago
Cronos Group Shares Rise After Swing to Q2 Earnings, Higher Revenue
MT Newswires · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.